Who Is a Candidate, and Who Should Wait NAD+ and peptide therapies tend to appeal to generally healthy adults working toward specific wellness goals
Localized injuries benefit more from the concentrated delivery of subcutaneous administration
Complete Our Online Intake Form Fill out our short online intake form
For millions, it's a persistent, confidence-sapping battle that extends well into adulthood, resisting conventional treatments and causing immense frustration
Loading phase protocol (acute injury or initial treatment): Dose: 500 mcg to 1 mg per injection Frequency: Once daily Duration: 7 to 10 days Injection site: Subcutaneous, ideally near the area of concern Timing: Morning or evening, consistency matters more than specific time Maintenance phase protocol: Dose: 500 mcg to 1 mg per injection Frequency: 2 to 3 times per week Duration: 4 to 8 weeks total protocol length Cycle recommendation: 2 months on, 2 months off Unlike traditional BPC-157 acetate, which is often administered twice daily due to its shorter half-life, the enhanced stability of the arginate form typically allows for once-daily dosing during the loading phase
Cerebellar tDCS does not enhance performance in an implicit categorization learning task
